Christian Glennie
Christian Glennie joined the healthcare team at Edison Investment Research in January 2012 and has 11 years' experience covering the global biotech/pharmaceutical sector as an analyst and a journalist. He came to Edison having held senior analyst and editorial roles at EvaluatePharma and EP Vantage. Christian Glennie also has prior experience as a marketing analyst at Zeneca Agrochemicals.
Recent Quotes
"ATHX's MultiStem in ischemic stroke showed a favorable safety profile."
—
Christian Glennie, Edison Investment Research
(5/5/15)
more >
Due to permission requirements, not all quotes are shown.